AW
CRSP icon

Alteri Wealth’s CRISPR Therapeutics CRSP Stock Holding History

Alteri Wealth’s Portfolio CRSP Stock Details CRSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$306K Sell
5,603
-1
-0% -$53 0.08% 231
2026
Q1 		$267K Sell
5,604
-14
-0.2% -$738 0.09% 233
2025
Q4 		$295K Buy
5,618
+12
+0.2% +$719 0.1% 228
2025
Q3 		$363K Buy
5,606
+78
+1% +$4.48K 0.12% 185
2025
Q2 		$269K Buy
+5,528
New +$214K 0.1% 214
2025
Q1 		– Sell
-5,525
Closed -$217K – 254
2024
Q4 		$217K Buy
+5,525
New +$261K 0.06% 229

Other funds holding CRSP

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
IEFM
IQ EQ Fund Management Dublin 2, Ireland $1.57B AUM 40.42% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
SC
Slow Capital Greenbrae, California $857M AUM 38.3% 1-Year Est. Return
CIA
Concurrent Investment Advisors Tampa, Florida $11.8B AUM 31.86% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $22.6B AUM 40.24% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Alteri Wealth's CRSP Position: Q2 2026 in Review

Alteri Wealth reduced its CRISPR Therapeutics (CRSP) stake by 0.02% in Q2 2026, selling an estimated $53 and leaving 5,603 shares worth $306K. The position accounts for 0.08% of the portfolio, ranked #231.

Alteri Wealth first reported a position in CRSP in Q4 2024 and has held it in 6 quarters since. The position peaked at $363K in Q3 2025. 167 funds tracked by Wall St. Rank hold CRSP as of Q2 2026.

  • Alteri Wealth held 5,603 shares of CRISPR Therapeutics worth $306K as of Q2 2026.
  • Alteri Wealth sold 1 CRISPR Therapeutics share in Q2 2026, an estimated $53.
  • CRISPR Therapeutics made up 0.08% of Alteri Wealth's portfolio in Q2 2026, its #231 holding.
  • Alteri Wealth first reported a position in CRISPR Therapeutics in Q4 2024 and has held it in 6 quarters since.
  • Alteri Wealth's CRISPR Therapeutics position peaked at $363K in Q3 2025.
  • 167 funds tracked by Wall St. Rank held CRISPR Therapeutics as of Q2 2026.

Based on Alteri Wealth's 13F filing for Q2 2026, filed 29 Jul 2026.